PharmEasy parent API Holdings withdraws Rs 6,250 cr DRHP, eyes rights issue

API Holdings has pulled its 2021-filed Rs 6,250 crore IPO papers from SEBI and is weighing a rights issue to existing backers including Prosus, TPG and Temasek. The retreat reflects cooling appetite for new-age listings and follows the Rs 4,546 crore Thyrocare buy that stretched the balance sheet.

— FiledWed, 27 May, 2026, 03:16 IST·First seen Wed, 27 May, 2026, 03:10 IST·Source Moneycontrol · News Web

What happened

API Holdings, parent of online pharmacy PharmEasy, has withdrawn its Rs 6,250 crore DRHP filed with SEBI in 2021 and is weighing a rights issue to existing

Key facts

  • Rs 6,250 crore IPO
  • Rs 4,546 crore Thyrocare acquisition
  • DRHP filed November 2021
  • board met August 19

Why this matters

API Holdings' stretched balance sheet post-Thyrocare and frozen public exit opens a window for strategic tie-ups, asset carve-outs, or distressed M&A approaches at far more reasonable multiples.

Also reported by